--- title: 'Senior Medical Science Liaison (Texas) at Summit Therapeutics' canonical: 'https://feeny.ai/job/senior-medical-science-liaison-texas-summit-therapeutics-united-states-1nxejb2p96nq' type: 'job' last_seen: '2026-09-04' --- # Senior Medical Science Liaison (Texas) at Summit Therapeutics - **Company:** Summit Therapeutics - **Location:** United States - **Compensation:** $200k–$235k - **Work type:** remote - **Posted:** 2026-08-26 - **Last confirmed live:** 2026-09-04 - **Apply:** https://job-boards.greenhouse.io/summittherapeutics/jobs/4381618009 ## Job description About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland. Regional Support: (TX, OK, AR, LA, KS, MO) Overview of Role: The Regional Medical Science Director (also referred to as MSL) is a field based scientific expert that strategically supports the scientific and business objectives of cancer therapeutic areas across the product life cycle. MSLs are the primary communicators of Summit Therapeutics science within a specific geography with healthcare professionals. MSLs are the field scientific experts on Immuno-Oncology and treatment options within this therapeutic area. They combine strong business acumen, clinical expertise, market awareness, and serve as a conduit of information to a cross functional customer base internally within Summit Therapeutics. Based on therapeutic needs and product life cycles, teams may focus on certain responsibilities, including clinical development and pipeline support. Role and Responsibilities: - Develop, execute and maintain high impact territory plans, including HCP and Investigator engagement plans in alignment with therapeutic area medical and scientific objectives with a focus on quality. - Support clinical development and research initiatives across development at the request of R&D to include, but not limited to, site evaluation and identification, recruitment, investigator meetings, external expert identification, and involving experts to generate scientific data including investigator-sponsored trials. - Identify, gain access to, and develop professional customer centric based relationships with external experts in Immuno-Oncology within assigned geography. - Provide education relative to disease state, therapeutic landscape and Summit Therapeutics products across the product lifecycle to healthcare providers and researchers. - Participate, monitor, and provide insights to Summit from relevant scientific meetings in relevant geography. - Continuously maintain self-education on market issues/trends, product knowledge, and new therapeutic areas of interest as it pertains to specific business responsibilities, including creating awareness and relationships for Summit Therapeutics in the Medical community. - Actively participate in relevant team meetings, organizational activities, and Country-driven medical affairs activities (e.g. advisory boards, Masterclasses, Round-tables) - Create, maintain, and collaborate in relationships with Cross-Functional partnerships, as appropriate, to develop and execute Account plans designed to support and meet shared scientific or business objectives. - All other duties as assigned Experience, Education and Specialized Knowledge and Skills: - Doctoral degree in the health sciences from an accredited university required (MD, PhD, PharmD, or equivalent). Significant clinical and/or industry experience in oncology and cancer therapeutic area may be accepted in lieu of education requirements. - A minimum of 5+ years of solid tumor cancer experience with a preference in GI, bladder, renal cell tumors. - Greater than or equal to 5+ years of clinical, scientific/research, or industry related experience or equivalent preferred. - A minimum of 2+ years as a Medical Science Liaison required. - Previous pharmaceutical industry experience within relevant scientific discipline preferred. - The MSL must possess and be able to demonstrate past achievements in: - Understanding, analyzing and communicating complicated scientific concepts and data. - Building credible relationships with prominent HCPs. - Ability to independently identify and translate corporate needs into an action plan that will achieve objectives. - Self-motivation to achieve and exceed goals. - Problem solving and analytic skills. - Critical thinking. - Ability to work independently. - An essential requirement of the position is to meet health care industry representative (HCIR) credentialing requirements to gain entry into facilities and organizations that in your assigned territory. These HCIR credentialing requirements may include, but are not limited to, background checks, drug screens, and proof of immunization/vaccination for various diseases. - Other requirements: - Must be willing to travel up to 75% of the time. - Proficient user of standard MS Office suite (e.g., Word, Excel), experience using electronic document management systems, and document review tools desirable - Strong computer and database skills - Attention to detail, accuracy and confidentiality. - Clear and concise oral and written communication skills - Excellent organizational skills - Must be able to effectively multi-task and manage time-sensitive and highly confidential documents. - Prioritize conflicting demands. - Work in a fast-paced, demanding and collaborative environment This is the pay for this position Pay Transparency $200,000—$235,000 USD Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation. Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at recruiting@smmttx.com to obtain prior written authorization before referring any candidates to Summit. Summit Therapeutics Inc. is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment, hiring, training or promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. ## About Summit Therapeutics ## Company Overview - **One-liner**: Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on discovering, developing, and commercializing novel bispecific antibody therapies, with its lead candidate ivonescimab targeting PD-1 and VEGF for multiple solid tumors. - **Entity Type**: Public (NASDAQ: SMMT) - **Headquarters**: Miami, Florida, USA (with additional offices in Palo Alto, CA; Princeton, NJ; Oxford, UK; and Dublin, Ireland) - **Founded**: 2003 - **Founders**: Not publicly disclosed on the company website; the company was founded in 2003. ## Core Business - **Primary industry**: Biopharmaceuticals / Oncology - **Target customers**: B2B (healthcare providers, patients, and caregivers) with a focus on resolving serious unmet medical needs in oncology - **Mission statement**: "To resolve serious, unmet medical needs for the betterment of overall human health." [smmttx.com](https://smmttx.com/company/about-us/default.aspx) ## Products & Services - **Ivonescimab (SMT112)**: A novel, potential first-in-class investigational bispecific antibody targeting both PD-1 and VEGF. It is designed to combine immunotherapy (PD-1 blockade) with anti-angiogenesis (VEGF blockade) into a single molecule. Currently being studied in several global Phase 3 clinical trials for non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and head and neck squamous cell carcinoma (HNSCC). Licensed from Akeso, Inc. (HKEX: 9926.HK) for territories including the U.S., Canada, Europe, Japan, Latin America, the Middle East, and Africa. [smmttx.com](https://smmttx.com/pipeline/default.aspx) ## Market Standing - **Valuation/Market Cap**: Approximately $2.7 billion (as of recent data) [linkedin.com](https://www.linkedin.com/company/summit-therapeutics) - **Key Metric**: Annual revenue of approximately $705,000 (reported). The company is pre-commercialization and heavily investing in R&D. Total funding raised since IPO (2015) is not disclosed, but the company has a strong cash position from equity offerings. - **Notable Investors/Partners**: Akeso, Inc. (key licensing partner for ivonescimab). The company is publicly traded with institutional and retail investors. - **Growth Signals**: - Headcount grew 72.5% year-over-year to 244 employees. [linkedin.com](https://www.linkedin.com/company/summit-therapeutics) - Multiple global Phase 3 trials actively recruiting (HARMONi, HARMONi-3, HARMONi-7, HARMONi-GI3, ILLUMINE). - Over 4,000 patients have been treated with ivonescimab across all clinical trials globally. [smmttx.com](https://smmttx.com/pipeline/default.aspx) - Achieved Great Place to Work® Certification. [smmttx.com](https://smmttx.com/careers/careers-overview/default.aspx) ## Competitive Advantages - **Novel Mechanism**: Ivonescimab is a first-in-class bispecific antibody targeting both PD-1 and VEGF simultaneously, potentially offering superior efficacy and fewer side effects compared to combination therapies. - **Speed and Execution**: The company emphasizes "high-speed execution in commercialization" and has rapidly initiated multiple Phase 3 trials. - **Global Reach**: Licensed territories cover major markets (U.S., Canada, Europe, Japan, Latin America, Middle East, Africa) with a strong partner (Akeso) in the rest of the world. - **Strong Balance Sheet**: With a $2.7B market cap and public listing, the company has access to capital markets to fund its pipeline. ## Strategic Focus - **Current priorities**: Advancing ivonescimab through Phase 3 clinical trials across multiple solid tumor indications (NSCLC, CRC, HNSCC), with the goal of regulatory approval and commercialization. - **Future direction**: Expanding the pipeline into additional solid tumors and leveraging the bispecific platform for future therapies. The company is focused on becoming a leading oncology player. - **Near-term milestones**: Data readouts from ongoing Phase 3 trials, potential regulatory submissions, and building commercial infrastructure. ## Why Work Here - **Culture**: The company has achieved Great Place to Work® Certification, indicating a positive, supportive, and fulfilling work environment. Core values include Commitment to People, Integrity, Passion for Excellence, Purposeful Urgency, Accountability, and Collaboration. [smmttx.com](https://smmttx.com/careers/careers-overview/default.aspx) - **Work Environment**: Fast-paced, high-energy atmosphere focused on innovation and collaboration. The company emphasizes "making a significant difference in patients’ lives." - **Benefits (U.S.)**: - 401(k) with 6% employer match - Employee Stock Purchase Plan (ESPP) with 15% discount up to the annual federal limit - Flexible Spending Account - Commuter Benefit - Onsite lunch provided - **Benefits (U.K.)**: - Private Medical Insurance - Employee Assistance Program - Life Assurance Policy - Company Pension Contributions - ESPP - **Remote/Hybrid Policy**: Not explicitly stated, but multiple office locations suggest a hybrid or on-site presence is expected for many roles. - **Open Roles**: 25 active job postings (as of recent data) including Senior Director of Sales Operations, Clinical Scientists, Medical Science Liaisons, and Drug Product MSAT roles. [greenhouse.io](https://job-boards.greenhouse.io/summitherrapeutics) - **Headcount Growth**: 72.5% year-over-year growth signals a scaling organization with opportunities for career advancement. ## Sources 1. [smmttx.com - About Us](https://smmttx.com/company/about-us/default.aspx) 2. [smmttx.com - Investor Relations Overview](https://www.smmttx.com/overview/default.aspx) 3. [smmttx.com - Pipeline](https://smmttx.com/pipeline/default.aspx) 4. [smmttx.com - Careers Overview](https://smmttx.com/careers/careers-overview/default.aspx) 5. [linkedin.com - Summit Therapeutics Company Page](https://www.linkedin.com/company/summit-therapeutics) 6. [greenhouse.io - Summit Therapeutics Careers](https://job-boards.greenhouse.io/summitherrapeutics) ## Other roles at Summit Therapeutics - [Director, Commercial Analytics & Information](https://feeny.ai/job/director-commercial-analytics-information-summit-therapeutics-princeton-4sy7b3h9tjvz) — Princeton, NJ - [Director, Marketing Operations](https://feeny.ai/job/director-marketing-operations-summit-therapeutics-princeton-5kjc188q3z1y) — Princeton, NJ - [Project Manager - CONTRACT](https://feeny.ai/job/project-manager-contract-summit-therapeutics-princeton-nj-mjpba1rbgzgc) — Princeton NJ, United States - [Senior Manager, CRM IT](https://feeny.ai/job/senior-manager-crm-it-summit-therapeutics-princeton-nj-9q5d6bn5sa0f) — Princeton NJ, United States - [IT Business Analyst - G&A](https://feeny.ai/job/it-business-analyst-g-a-summit-therapeutics-palo-alto-8xxzscj7r2ez) — Palo Alto, CA - [IT Helpdesk Analyst](https://feeny.ai/job/it-helpdesk-analyst-summit-therapeutics-palo-alto-xkn1kh9je3fc) — Palo Alto, CA - [Associate Director, Project Management - Medical Affairs (Princeton, NJ or Palo Alto, CA)](https://feeny.ai/job/associate-director-project-management-medical-affairs-princeton-nj-or-palo-alto-h21rbxapf222) — Princeton NJ, United States - [Senior Medical Science Liaison (South)](https://feeny.ai/job/senior-medical-science-liaison-south-summit-therapeutics-united-states-jmrft1h5njy5) — United States - [Senior Medical Science Liaison (Northeast)](https://feeny.ai/job/senior-medical-science-liaison-northeast-summit-therapeutics-united-states-kz9wzmdv6wgq) — United States - [Senior Medical Science Liaison (Mountain West)](https://feeny.ai/job/senior-medical-science-liaison-mountain-west-summit-therapeutics-united-states-4zp7v9kdvj58) — United States